Carregant...
Precision Medicines’ Impact on Orphan Drug Designation
The incentives provided under the Orphan Drug Act (ODA) have been credited for catalyzing the marketing approval of drugs for the treatment of rare diseases by the US Food and Drug Administration. Orphan drug designation, the granting of special status to drugs or biologics (“drugs”) for the treatme...
Guardat en:
| Publicat a: | Clin Transl Sci |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6853264/ https://ncbi.nlm.nih.gov/pubmed/31297924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12667 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|